Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Targeted radioactive therapy for prostate cancer reply — Michael S. Hofman (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Targeted radioactive therapy for prostate cancer reply
Shared by
Shahneen Sandhu
University of Melbourne
Targeted radioactive therapy for prostate cancer reply
Article
2021
en
Authors
+2 more
MH
Michael S. Hofman
Shahneen Sandhu
University of Melbourne
RF
Roslyn J. Francis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2021
Targeted radioactive therapy for prostate cancer – Authors' reply
Michael S. Hofman
,
Shahneen Sandhu
,
Roslyn J. Francis
,
Ian D. Davis
,
Louise Emmett
Article
2018
[Lu-177]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer reply
Michael S. Hofman
,
John Violet
,
Rodney J. Hicks
,
Shahneen Sandhu
Letter
2018
[ 177 Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer – Author's reply
Michael S. Hofman
,
John Violet
,
Rodney J. Hicks
,
Shahneen Sandhu
Article
2011
Beyond Hormone Therapy for Prostate Cancer with PARP inhibitors
Johann S. de Bono
,
Shahneen Sandhu
,
Gerhardt Attard
Article
2019
Peptide‐Modified Dendrimer Nanoparticles for Targeted Therapy of Colorectal Cancer
Mariana R. Carvalho
,
Cristiana R. Carvalho
,
F. Raquel Maia
,
David Caballero
,
Subhas C. Kundu
,
Rui L Reis
,
Joaquím M. Oliveira
Discussion(0)
No comments yet. Be the first to comment.